Clinical Trial Update: Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A terminated Phase 1/2 clinical trial evaluating sunitinib, cyclophosphamide, and methotrexate for metastatic breast cancer; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• METHOTREXATE (METHOTREXATE)
• Sunitinib (sunitinib)

Snippet

Sponsor: University of California, San Francisco | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2013-02-12